Cargando…
Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namel...
Autores principales: | Suehara, Yoshiyuki, Kubota, Daisuke, Kikuta, Kazutaka, Kaneko, Kazuo, Kawai, Akira, Kondo, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512344/ https://www.ncbi.nlm.nih.gov/pubmed/23226966 http://dx.doi.org/10.1155/2012/425636 |
Ejemplares similares
-
Application of Proteomics to Soft Tissue Sarcomas
por: Kondo, Tadashi, et al.
Publicado: (2012) -
Gene Expression Network Analysis of ETV1 Reveals KCTD10 as a Novel Prognostic Biomarker in Gastrointestinal Stromal Tumor
por: Kubota, Daisuke, et al.
Publicado: (2013) -
miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
por: Kubota, Daisuke, et al.
Publicado: (2016) -
Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance
por: Kim, Youngji, et al.
Publicado: (2016) -
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma
por: Kim, Youngji, et al.
Publicado: (2021)